HDH Cerebral Embolic Protection Device Is Safe During TAVR
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Randomized Evaluation of the TriGuard™ HDH Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions After TransCatheter Aortic Valve ImplanTation: The REFLECT I Trial
Eur Heart J 2021 May 17;[EPub Ahead of Print], AJ Lansky, R Makkar, T Nazif, S Messé, J Forrest, R Sharma, J Schofer, A Linke, D Brown, A Dhoble, P Horwitz, M Zang, F DeMarco, V Rajagopal, MG Dwyer, R Zivadinov, P Stella, J Rovin, H Parise, S Kodali, A Baumbach, J MosesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.